Nektar Therapeutics (NKTR) | Jive Data

Google Sheets Add-onSheets Account

Profile Financials SEC Filings Insider Transactions Ownership

Loading NKTR…

Nektar Therapeutics (NKTR) | Jive Data

Google Sheets Add-onSheets Account

Profile Financials SEC Filings Insider Transactions Ownership

SEC filing

Nektar Therapeutics

NKTR · CIK 906709

4 · Aug 20, 2026 · Director, President & CEO ROBIN HOWARD W sold 418 shares at $71.98/share ($30,088)

4

Director, President & CEO ROBIN HOWARD W sold 418 shares at $71.98/share ($30,088)

Filed: Aug 20, 2026
Period: Aug 18, 2026
Accession: 0001193125-26-359586
Filer: NEKTAR THERAPEUTICS

View on SEC.gov All SEC filings

Filing document

xslF345X06/ownership.xml

xslF345X06/ownership.xmlSEC.gov

Other files

Graphics and non-inline formats (not embedded below).

4ownership.xml
Open SEC.gov